Vifor Fresenius Medical Care Renal Pharma
Clinical trials sponsored by Vifor Fresenius Medical Care Renal Pharma, explained in plain language.
-
New drug patiromer safely lowers dangerous potassium levels in chinese kidney patients
Disease control CompletedThis study tested a drug called patiromer in 262 Chinese adults with chronic kidney disease and high potassium levels (hyperkalemia). The goal was to see if patiromer could safely lower potassium and allow patients to continue important heart-protective medications. Participants …
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New drug offers hope for kidney patients suffering from unbearable itching
Symptom relief CompletedThis study tested a drug called difelikefalin in 260 Chinese adults on hemodialysis who had moderate-to-severe itching. Participants received either the drug or a placebo for 12 weeks, with an optional 14-week extension. The main goal was to see if the drug reduced itching intens…
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC